Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Sporadic Small (≤20mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis

Sporadic Small (≤20mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of... Ann Surg Oncol (2017) 24:2603–2610 DOI 10.1245/s10434-017-5946-8 O R I G IN AL ARTI CL E – EN DO CRIN E T UM ORS Sporadic Small (£20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis 1 1 1 1 Claudio Ricci, MD , Riccardo Casadei, MD , Giovanni Taffurelli, MD , Carlo Alberto Pacilio, MD , 1 2 2 1 Davide Campana, MD , Valentina Ambrosini, MD , Santini Donatella, MD , and Francesco Minni, MD Department of Internal Medicine and Surgery (DIMEC), Chirurgia Generale-Minni, Alma Mater Studiorum-Universita ` di Bologna, Bologna, Italy; Department of Specialized Diagnostic and Experimental Medicine (DIMES), Bologna, Italy ABSTRACT times higher than the benefits. The risk difference of distant Background. The management of small (B20 mm), non- metastases, G3 lesions, G2–G3 lesions, stage III/IV, functioning pancreatic neuroendocrine neoplasms (pNENs) microscopic vascular invasion, death, and recurrence of the remains under debate. The European Neuroendocrine disease were lower in small NF-PNETs than large ones. Tumor Society guidelines advocate the possibility of a The related LHH values suggested that a watch-and-wait conservative approach. policy never provided a benefit. Methods. A systematic literature search http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Sporadic Small (≤20mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis

Loading next page...
1
 
/lp/springer_journal/sporadic-small-20mm-nonfunctioning-pancreatic-neuroendocrine-neoplasm-Q5aBRXNiAL

References (22)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
DOI
10.1245/s10434-017-5946-8
pmid
28681158
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2017) 24:2603–2610 DOI 10.1245/s10434-017-5946-8 O R I G IN AL ARTI CL E – EN DO CRIN E T UM ORS Sporadic Small (£20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis 1 1 1 1 Claudio Ricci, MD , Riccardo Casadei, MD , Giovanni Taffurelli, MD , Carlo Alberto Pacilio, MD , 1 2 2 1 Davide Campana, MD , Valentina Ambrosini, MD , Santini Donatella, MD , and Francesco Minni, MD Department of Internal Medicine and Surgery (DIMEC), Chirurgia Generale-Minni, Alma Mater Studiorum-Universita ` di Bologna, Bologna, Italy; Department of Specialized Diagnostic and Experimental Medicine (DIMES), Bologna, Italy ABSTRACT times higher than the benefits. The risk difference of distant Background. The management of small (B20 mm), non- metastases, G3 lesions, G2–G3 lesions, stage III/IV, functioning pancreatic neuroendocrine neoplasms (pNENs) microscopic vascular invasion, death, and recurrence of the remains under debate. The European Neuroendocrine disease were lower in small NF-PNETs than large ones. Tumor Society guidelines advocate the possibility of a The related LHH values suggested that a watch-and-wait conservative approach. policy never provided a benefit. Methods. A systematic literature search

Journal

Annals of Surgical OncologySpringer Journals

Published: Jul 5, 2017

There are no references for this article.